“While Anthropic, the company behind the Claude AI chatbot, reiterated its commitment to Amazon, we see this move with Google ...

Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with ...

The Shroud of Turin is believed by some to be the cloth in which Jesus was buried, but it has a controversial history ...

As a result of two public hearings during its Tuesday, October 21 regular meeting, the Chaffee Board of County Commissioners ...

Vertex should earn other important approvals through 2030 that could jolt its stock price. It's developing a treatment called ...

Vertex Pharmaceuticals Inc. (($VRTX)) announced an update on their ongoing clinical study. Vertex Pharmaceuticals Inc. is conducting a Phase 3 ...

This study update could positively impact Vertex Pharmaceuticals and Moderna’s stock performance, as successful results may enhance their competitive position in the cystic fibrosis treatment market.

BioMarin will host a conference call and webcast to discuss third quarter 2025 financial results today, Monday, October 27, 2025, at 4:30 p.m. ET. This event can be accessed through this link or on ...

Singapore, Singapore, October 27th, 2025, ChainwireStableStock, the on-chain stock-liquidity infrastructure, has partnered ...

Learn how to analyze entire user conversations with LangSmith's multi-turn evaluations, designed for better customer support and engagement.